|
|
Phase II COVID-19 Vaccines
This site presents COVID-19 vaccines that are currently in Phase II clinical trials as of November 28, 2020.
Current Phase II COVID-19 vaccines include:
- AG0301-COVID19
- Clinical trial ID:
- Phase I/II: NCT04463472
- Age subgroups: 20-65 years
- Location: Japan
- Phase I/II: NCT04527081
- Age subgroups: 20-65 years
- Location: Japan
- Type: DNA vaccine
- Manufacturer: AnGes, Inc.
- VIOLIN: 5780
- VO: VO_0005165
- ARCT-021
- Other names: LUNAR-COV19
- Clinical trial ID:
- Phase I/II: NCT04480957
- Age subgroups:
- Phase I: 21-55 years
- Phase II: 21-55 years; 56-80 years
- Location: Singapore
- Type: RNA vaccine
- Manufacturer: Arcturus Therapeutics; Duke-NUS Medical School
- VIOLIN: 5781
- VO: VO_0005164
- BriLife
- Other names: IIBR-100
- Clinical trial ID:
- Phase I/II: NCT04608305
- Age subgroups:
- Phase I: 18-55 years
- Phase II: 18-55 years; 56-85 years
- Location: Israel
- Type: Recombinant vector vaccine
- Manufacturer: Israel Institute for Biological Research; Weizmann Institute of Science
- COVID-19 inactivated virus vaccine by Beijing Minhai Biotechnology
- Clinical trial ID:
- Type: Inactivated or "killed" vaccine
- Manufacturer: Beijing Minhai Biotechnology Co., Ltd.
- COVID-19 inactivated virus vaccine by Chinese Academy of Medical Sciences
- Clinical trial ID:
- Phase I/II: NCT04412538
- Age subgroups: 18-59 years
- Location: China
- Phase I/II: NCT04470609
- Age subgroups: 60 years and above
- Location: China
- Type: Inactivated or “killed” vaccine
- Manufacturer: Institute of Medical Biology, Chinese Academy of Medical Sciences
- VIOLIN: 5785
- VO: VO_0005167
- COVID-19 protein subunit vaccine by Sanofi and GSK
- Clinical trial ID:
- Phase I/II: NCT04537208
- Age subgroups: 18-49 years; 50 years and above
- Location: USA
- Type: Subunit vaccine
- Manufacturer: Sanofi Pasteur; GSK
- CVnCoV
- Clinical trial ID:
- Phase II: NCT04515147
- Age subgroups: 18-60 years; 61 years and above
- Location: Panama, Peru
- Type: RNA vaccine
- Manufacturer: Curevac
- VIOLIN: 5786
- VO: VO_0005168
- DelNS1-2019-nCoV-RBD-OPT1
- Clinical trial ID:
- Type: Recombinant vector vaccine
- Manufacturer: Beijing Wantai Biological Pharmacy; Xiamen University
- EpiVacCorona
- Clinical trial ID:
- Phase I/II: NCT04527575
- Age subgroups:
- Phase I: 18-30 years
- Phase II: 18-60 years
- Location: Russia
- Type: Peptide vaccine
- Manufacturer: FBRI State Research Center of Virology and Biotechnology
- GX-19
- Clinical trial ID:
- Phase I/II: NCT04445389
- Age subgroups: 18-50 years
- Location: South Korea
- Type: DNA vaccine
- Manufacturer: Genexine
- VIOLIN: 5788
- VO: VO_0005170
- INO-4800
- Clinical trial ID:
- Phase I/II: NCT04447781
- Age subgroups:
- Phase I: 19-64 years
- Phase II: 19-50 years; 51-64 years
- Location: South Korea
- Type: DNA vaccine
- Manufacturer: Inovio Pharmaceuticals
- Publications:
- Smith et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020; 11(1); 2601. [PubMed: 32433465].
- VIOLIN: 5793
- VO: VO_0005172
- KBP-COVID-19
- Clinical trial ID:
- Phase I/II: NCT04473690
- Age subgroups: 18-49 years; 50-70 years
- Type: Subunit vaccine
- Manufacturer: Kentucky BioProcessing
- VIOLIN: 5792
- VO: VO_0005171
- QazCovid-in
- Clinical trial ID:
- Phase II: NCT04530357
- Age subgroups:
- Phase I: 18-50 years
- Phase II: 18 years and above
- Location: Kazakhstan
- Type: Inactivated or "killed" vaccine
- Manufacturer: Research Institute for Biological Safety Problems; National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan
- RBD-CuMVTT
- Clinical trial ID:
- Phase II: NCT04466085
- Age subgroups: 18-59 years
- Location: China
- Type: Virus Like Particle
- Manufacturer: Anhui Zhifei Longcom Biopharmaceutical; Institute of Microbiology, Chinese Academy of Sciences
- Publications:
- Dai et al. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020; 182(3); 722-733. [PubMed: 32645327].
- VIOLIN: 5764
- VO: VO_0005142
- RBD-HBsAg VLP
- Clinical trial ID:
- Phase I/II: ACTRN12620000817943
- Age subgroups:
- Phase I: 18-45 years
- Phase II: 18-79 years
- Location: Australia
- Type: Virus Like Particle
- Manufacturer: Serum Institute of India
- V591
- Clinical trial ID:
- Phase I/II: NCT04498247
- Age subgroups: 18-55 years; 56 years and above
- Location: USA, Austria, Belgium
- Type: Recombinant vector vaccine
- Manufacturer: Merck
- ZyCoV-D
- Clinical trial ID:
- Phase I/II: CTRI/2020/07/026352
- Age subgroups:
- Phase I: 18-45 years
- Phase II: 18-79 years
- Location: Australia
- Type: DNA vaccine
- Manufacturer: Zydus Cadila
- VIOLIN: 5778
- VO: VO_0005162
Provenance: All data in Cov19VaxKB originates from manual curation of reliable resources
Note: The page was updated on November 28, 2020. We plan to update this page on a weekly or even a daily basis. Please provide us with any new information that you believe would be useful if included on the website.
|
